The Effects of Nicotine Chewing Gum in Parkinson's Disease
NCT02452125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2017-07-28
Summary
The objective of this experiment is:
To determine if nicotine chewing gum will improve acute episodes of orthostatic hypotension in PD subjects.
Conditions
- Low Blood Pressure
- Parkinsons Disease
Interventions
- DIETARY_SUPPLEMENT
-
Nicotine gum
Nicotine chewing gum
Sponsors & Collaborators
-
New York Institute of Technology
lead OTHER
Principal Investigators
-
Joanne Donoghue, PhD · New York Institute of Technology
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2017-06-01
- Completion
- 2017-06-01
Countries
- United States
Study Locations
More Related Trials
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
NCT04971954 ·Status: RECRUITING ·Phase: NA
-
Nicotine Replacement Therapy in Nicotine-dependent Arrestees
NCT02905734 ·Status: COMPLETED ·Phase: PHASE4
-
Test of Novel Drug for Smoking Cessation
NCT02217527 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction
NCT00264342 ·Status: COMPLETED
-
A Dietary Supplement for Early Cigarette Withdrawal
NCT02042521 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Nicotine on Brain Reward Pathways
NCT02346539 ·Status: COMPLETED ·Phase: PHASE1
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Sympathovagal Balance in Smoking Cessation
NCT01474265 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers
NCT01034020 ·Status: COMPLETED ·Phase: PHASE1
-
Reduced Nicotine Cigarette Purchasing Decisions
NCT04999644 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
NCT02906644 ·Status: COMPLETED ·Phase: PHASE2
-
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
NCT02825459 ·Status: COMPLETED ·Phase: NA
-
Nicotine Virtual Reality Conditioned Place Preference
NCT06259630 ·Status: WITHDRAWN ·Phase: PHASE4
-
Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?
NCT01730846 ·Status: COMPLETED ·Phase: PHASE2
-
Bupropion Alone or Combined With Nicotine Gum
NCT01621022 ·Status: COMPLETED ·Phase: PHASE4
-
Acute and Chronic Nicotine Modulation of Reinforcement Learning
NCT01830842 ·Status: COMPLETED ·Phase: NA
-
Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray
NCT01136642 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
NCT02439944 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Oral Tolerability Of Two Nicotine Dosage Forms
NCT00682461 ·Status: COMPLETED ·Phase: PHASE1
-
N-Acetylcysteine and Smoking Reduction
NCT00751257 ·Status: COMPLETED ·Phase: PHASE2
-
Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence
NCT00390923 ·Status: TERMINATED ·Phase: NA
-
Memory Improvement Through Nicotine Dosing (MIND) Study
NCT02720445 ·Status: COMPLETED ·Phase: PHASE2
-
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
NCT00939029 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism
NCT05947162 ·Status: NOT_YET_RECRUITING ·Phase: NA